Ginkgo Bioworks Holdings's total assets for Q3 2024 were $1.48B, a decrease of -8.88% from the previous quarter. DNA total liabilities were $682.94M for the fiscal quarter, a -13.79% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.